Showing results (161-170 of 255) with videos related to
Sort By:
Pageof 26
Nature Communications|November 17, 2023
Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosisSadiya Parveen, Jessica Shen, Shichun Lun, et al.Journal of Medicinal Chemistry|March 21, 2019
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine ProdrugsLukáš Tenora, Jesse Alt, Ranjeet P Dash, et al.JCI Insight|August 19, 2016
FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalitiesRana Rais, Weiwei Jiang, Huihong Zhai, et al.Journal of Medicinal Chemistry|July 2, 2019
The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D3 Receptor (D3R) Selective AgonistsFrancisco O Battiti, Sophie L Cemaj, Adrian M Guerrero, et al.Bioorganic & Medicinal Chemistry|February 5, 2015
Using click chemistry toward novel 1,2,3-triazole-linked dopamine D3 receptor ligandsThomas M Keck, Ashwini K Banala, Rachel D Slack, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 13, 2023
Dendrimer-enabled targeted delivery attenuates glutamate excitotoxicity and improves motor function in a rabbit model of cerebral palsyFan Zhang, Zhi Zhang, Jesse Alt, et al.Proceedings of the National Academy of Sciences of the United States of America|December 6, 2018
MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in miceBrittany A Riggle, Sanhita Sinharay, William Schreiber-Stainthorp, et al.Elife|May 22, 2014
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosisScott J Dixon, Darpan N Patel, Matthew Welsch, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2012
Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout miceRana Rais, Ajit G Thomas, Krystyna Wozniak, et al.Proceedings of the National Academy of Sciences of the United States of America|July 5, 2023
Inhibition of neutral sphingomyelinase 2 impairs HIV-1 envelope formation and substantially delays or eliminates viral reboundSeung-Wan Yoo, Abdul A Waheed, Pragney Deme, et al.Pageof 26